MAPT and amyloidosis: In support of this idea, a recent study demonstrates that inhibition of TNFα signaling prevents pre-plaque amyloid-associated neuropathology and reduces plaque accumulation and tau phosphorylation in transgenic mouse models of AD [55, 56].